Febuxostat

No adequate data about the safety of this medicine in pregnancy. Febuxostat should not be used during pregnancy.

It is unknown whether Febuxostat may pass into human breast milk. Hence it is unsafe to use if you are breastfeeding or if you are planning to breastfeed.

If during Febuxostat treatment, you feel dizziness, sleepiness or blurred vision, try to avoid driving.

No known interaction with alcohol. Alcohol is known to increase uric acid levels in the body and can worsen the underlying condition of gout. Avoid excessive consumption of alcohol.

Febuxostat is a medication used to lower blood uric acid levels. It is commonly prescribed for people with gout, a condition where uric acid crystals build up in the joints, causing pain, swelling, and inflammation. By reducing uric acid levels, Febuxostat helps prevent future gout attacks and long-term joint damage.

Febuxostat works by blocking an enzyme called xanthine oxidase, which is responsible for producing uric acid in the body. Reducing uric acid production helps prevent the formation of crystals that cause gout symptoms and reduces the risk of kidney stones.

Common side effects may include nausea, joint pain, rash, changes in liver enzymes, or mild diarrhoea. Some people may experience gout flares when first starting treatment. Rare but serious side effects include heart problems, severe allergic reactions, or liver issues. Seek medical attention if you notice chest pain, shortness of breath, swelling, or a severe rash.